NUMOTECH, INC. Strengthens Intellectual Property Protection with U.S. Patent for NUMOBAG-DISPOSABLE ISOLATION SYSTEM
Numobag Disposable Isolation System (N-DIS)
Patient in (N-DIS)
Transport patient in (N-DIS)
N-DIS is a portable, easily deployed, low cost, and sole use disposable infectious disease containment system allowing infectious patients to be safely transported while being fully encapsulated in a medical grade oxygen enriched clear polyethylene membrane. The N-DIS is designed to minimize risk to the patient and front-line personnel.
The N-DIS will be critical for first responder and medical staff protection against infectious and contagious pathogens such as SARS-CoV-2 COVID 19, A H5N1 Bird Flu, Human Metapneumovirus HMPV, Monkeypox Clade 1, Ebola and others while infected patients are being transported and/or isolated. Given constant re-exposure to respiratory pathogens, front-line medical personnel and first responders have the second highest rates of serious illness and death.
In 2023, the N-DIS was tested by the U.S. Army’s premier testing facility which reported that the isolation efficacy rating of the N-DIS was greater than 99.99% for viral and bacterial pathogens. The N-DIS can isolate contaminated patients during transport and protect first responders and medical personnel. The N-DIS can also protect vulnerable patients with severely compromised immune systems from airborne and surface pathogens.
The N-DIS is easy to use, low cost, disposable, and meets all quarantine protocols. The N-DIS contains the contaminated exhaust from the patient in a HEPA filter. The N-DIS membrane and HEPA filter exhaust system can be disposed of as biohazard waste after the patient is removed from the N-DIS.
“We are pleased to receive the new N-DIS patent. The N-DIS supplements standard PPE and captures viral and bacterial particles emitted from a patient’s body, preventing exposure to EMT personnel, first responders, nurses, and physicians from pathogenic biological airborne particulates,” said Robert Felton, President of Numotech, Inc. Felton continued, “The N-DIS will also be useful for U.S. military personnel who are facing an ever-growing challenge from infectious pathogens.”
Felton emphasized that “Along with rapid isolation of the patient, another critical operational consideration is patient safety. The emplacement of the N-DIS does not cause undue physical discomfort for the patient which would impede rapid and effective isolation. The patient can be transported and monitored comfortably.”
The N-DIS is expected to be a market leader based on performance, pricing, portability, and ease of implementation, personnel training, and disposability compared to competing products.
For more information contact:
Robert Felton
Numotech, Inc.
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
